Patient reported outcomes in benign multiple sclerosis

Multiple Sclerosis Journal

Volumn 17, Issue 7, 2011, Pages 876-884

  Hviid, Line E ^a   Healy, Brian C ^a   Rintell, David J ^a   Chitnis, Tanuja ^a   Weiner, Howard L ^a   Glanz, Bonnie I ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

benign; cognition; depression; fatigue; multiple sclerosis; quality of life

Indexed keywords

ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT REPORTED OUTCOMES; QUALITY OF LIFE; RATING SCALE; SOCIAL SUPPORT;

EID: 79959526179     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511398370     Document Type: Article

References (37)

1. Benito-Leon J, Morales JM, Rivera-Navarro J, Mitchell A. A review about the impact of multiple sclerosis on health-related quality of life. Disabil Rehabil. 2003 ; 25: 1291-1303
2. Hemmett L, Holmes J, Barnes M, Russell N. What drives quality of life in multiple sclerosis?. QJM. 2004 ; 97: 671-676 (Pubitemid 39359325)
3. Lobentanz IS, Asenbaum S, Vass K, et al. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol Scand. 2004 ; 110: 6-13 (Pubitemid 38850550)
4. Ford HL, Gerry E, Johnson MH, Tennant A. Health status and quality of life of people with multiple sclerosis. Disabil Rehabil. 2001 ; 23: 516-521 (Pubitemid 32591124)
5. Pfennings L, Cohen L, Ader H, et al. Exploring differences between subgroups of multiple sclerosis patients in health-related quality of life. J Neurol. 1999 ; 246: 587-591 (Pubitemid 29376285)
6. Pfaffenberger N, Pfeiffer KP, Deibl M, Hofer S, Gunther V, Ulmer H. Association of factors influencing health-related quality of life in MS. Acta Neurol Scand. 2006 ; 114: 102-108 (Pubitemid 44034257)
7. Pittock SJ, Mayr WT, McClelland RL, et al. Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study. Arch Neurol. 2004 ; 61: 679-686 (Pubitemid 38637684)
8. Putzki N, Fischer J, Gottwald K, et al. Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis. Eur J Neurol. 2009 ; 16: 713-720
9. Ramsaransing GS, De Keyser J. Benign course in multiple sclerosis: a review. Acta Neurol Scand. 2006 ; 113: 359-369 (Pubitemid 44046321)
10. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 ; 33: 1444-1452 (Pubitemid 14237132)
11. Pittock SJ, McClelland RL, Mayr WT, et al. Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. Ann Neurol. 2004 ; 56: 303-306 (Pubitemid 39037929)
12. Costelloe L, Thompson A, Walsh C, Tubridy N, Hutchinson M. Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease. J Neurol Neurosurg Psychiatry. 2008 ; 79: 1245-1248
13. Sayao AL, Devonshire V, Tremlett H. Longitudinal follow-up of 'benign' multiple sclerosis at 20 years. Neurology. 2007 ; 68: 496-500
14. Whitaker JN, McFarland HF, Rudge P, Reingold SC. Outcomes assessment in multiple sclerosis clinical trials: a critical analysis. Mult Scler. 1995 ; 1: 37-47
15. Amato MP, Zipoli V, Goretti B, et al. Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort. J Neurol. 2006 ; 253: 1054-1059 (Pubitemid 44441131)
16. Heaton RK, Nelson LM, Thompson DS, Burks JS, Franklin GM. Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis. J Consult Clin Psychol. 1985 ; 53: 103-110 (Pubitemid 15096165)
17. Rao SM, Hammeke TA, Speech TJ. Wisconsin Card Sorting Test performance in relapsing-remitting and chronic-progressive multiple sclerosis. J Consult Clin Psychol. 1987 ; 55: 263-265
18. Amato MP, Portaccio E, Stromillo ML, et al. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Neurology. 2008 ; 71: 632-638
19. Benedict RH, Fazekas F. Benign or not benign MS: a role for routine neuropsychological assessment?. Neurology. 2009 ; 73: 494-495
20. Amato MP, Ponziani G, Siracusa G, Sorbi S. Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol. 2001 ; 58: 1602-1606 (Pubitemid 32963224)
21. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald Criteria'. Ann Neurol. 2005 ; 58: 840-846 (Pubitemid 41746873)
22. Smith A. Symbol Digit Modalities Test: Manual. Los Angeles: Western Psychological Services, 1982.
23. Rao SM. Cognitive Function Study Group, National Multiple Sclerosis Society. A Manual for the Brief Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis. New York, NY: National Multiple Sclerosis Society; 1990.
24. Benedict RH. Effects of using same- versus alternate-form memory tests during short-interval repeated assessments in multiple sclerosis. J Int Neuropsychol Soc. 2005 ; 11: 727-736 (Pubitemid 41631486)
25. Benedict RH, Cookfair D, Gavett R, et al. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc. 2006 ; 12: 549-558 (Pubitemid 44070305)
26. Drake AS, Weinstock-Guttman B, Morrow SA, Hojnacki D, Munschauer FE, Benedict RH. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test. Mult Scler. 16: 228-237
27. Vickrey BG, Hays RD, Genovese BJ, Myers LW, Ellison GW. Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis. J Clin Epidemiol. 1997 ; 50: 557-569 (Pubitemid 27270205)
28. McHorney CA, Ware JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993 ; 31: 247-263
29. Minden SL, Orav J, Reich P. Depression in multiple sclerosis. Gen Hosp Psychiatry. 1987 ; 9: 426-434 (Pubitemid 17165071)
30. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol. 1988 ; 45: 435-437 (Pubitemid 18098285)
31. Putzki N, Katsarava Z, Vago S, Diener HC, Limmroth V. Prevalence and severity of multiple-sclerosis-associated fatigue in treated and untreated patients. Eur Neurol. 2008 ; 59: 136-142 (Pubitemid 351301256)
32. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci. 1994 ; 21: 9-14 (Pubitemid 24090744)
33. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis. 1994 ; 18 (Suppl 1). S79 - S583
34. Ritvo PG, Fischer JS, Miller DM, Andrews H, Paty DW and LaRocca NG. Multiple Sclerosis Quality of life inventory: A User's Manual. New York: National Multiple Sclerosis Society, 1997.
35. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement. 1977 ; 1: 385-401
36. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991 ; 32: 705-714
37. Rovaris M, Riccitelli G, Judica E, et al. Cognitive impairment and structural brain damage in benign multiple sclerosis. Neurology. 2008 ; 71: 1521-1526